European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical genetics<br />
an indication of the presence of FMR1 mRNA in female patients, which<br />
might have clinical implications regarding subsequent therapy.<br />
P0114. Prevalence of Fragile X Premutation and Intermediate/<br />
Grey Zone Alleles in a Basque Sample<br />
I. Arrieta Saez 1 , O. Peñagarikano 2 , M. Telez 1 , L. Valverde 1 , B. Criado 3 , J.<br />
Ramirez 1 , B. Ortega 1 , A. Gonzalez 4 , P. Flores 5 , C. Lostao 1 ;<br />
1 Department of <strong>Genetics</strong>, Faculty of Science and Technology, University of the<br />
Basque Country, Bilbao, Spain, 2 Departments of <strong>Human</strong> <strong>Genetics</strong>, Emory University<br />
School of Medicine, Atlanta, Georgia, 3 High School Da Maia, CESPU,<br />
Porto, Portugal, 4 Department of Internal Medicine, Faculty of Medicine, Basque<br />
Country University., Bilbao, Spain, 5 Department of Nursery, School of Nursery,<br />
University of the Basque Country, Bilbao, Spain.<br />
The Fragile X Syndrome (FXS; OMIM: 309550) is the most common<br />
inherited form of mental retardation. The molecular basis is usually the<br />
unstable expansion of a CGG trinucleotide repeat in the FMR 1 gene<br />
witch resides at chromosome position Xq27.3 and is coincident with<br />
the fragile site FRAXA.Based on the size of CGG secuence individuals<br />
are classified as having normal (6-54 CGG), premutation (55-200<br />
CGG) and full mutation alleles (>200 CGG). In adition the term intermediate/grey<br />
zone alleles has been used to define alleles with sizes<br />
at high range of normal alleles (35-54 CGG). Our previous cytogenetic<br />
and molecular screening for Fragile X Syndrome among mental retarded<br />
people of Basque and no Basque origin showed and absence<br />
of full mutation among Basque Sample. In the present work we analized<br />
the prevalence of FMR 1 premutated and intermedite/grey zone<br />
alleles, because recent clinical and molecular studies have changed<br />
the view that premutated alleles serve only as a source for full mutation<br />
alleles in transmision of FXS and that functional and phenotyphic<br />
effects are not associated with FMR 1 repeat size in the high end of<br />
the normal range alleles. A total of 298 unrelated male individuals were<br />
included in this study. The results obtained showed that the estimated<br />
prevalence of the intermediate/grey zone alleles 1/10 in Basque males<br />
(7.32 %) was lower than that reported in Caucasian populations. The<br />
prevalence of premutation alleles is 1/298 in males. The prevalence<br />
of premutation alleles in the general populated is estimated in 1/813<br />
males.<br />
P0115. 47,XYY male with the fragile X syndrome: rare genetic<br />
assotiation<br />
M. Simandlova, D. Novotna, Z. Musova, M. Havlovicova;<br />
Institute of Biology and Medical <strong>Genetics</strong>, Charles University Second Medical<br />
School and University Hospital Motol, Prague, Czech Republic.<br />
We report on a 26 year-old developmentally disabled man referred to<br />
our clinic for evaluation because of pregnancy of his younger sister.<br />
Cytogenetic and molecular analysis revealed a 47, XYY karyotype and<br />
the presence of a trinucleotide repeat expansion resulting in fragile<br />
X syndrome. Direct detection of the pre- and full mutation for the affected<br />
individual and his at-risk female relatives were performed . To<br />
our knowledge, this is the third report of concurrence of XYY and fragile<br />
X syndrome in the medical literature ( but one of these patients was<br />
46,XY/47,XYY mosaic male with fragile X syndrome) . Review of sex<br />
chromosome abnormalities associated with fragile X syndrome and<br />
phenotypic considerations are presented.<br />
This work is supported by the Grant number: 00000064203-MZCR.<br />
P01<strong>16</strong>. Cardiac evaluation of 34 individuals with Fragile X<br />
Syndrome<br />
M. Alikaşifoğlu, Y. Alanay, D. Alehan, G. Utine, B. Volkan-Salancı, K.<br />
Boduroğlu, D. Aktaş, E. Tunçbilek;<br />
Hacettepe University, Ankara, Turkey.<br />
Fragile X syndrome is the most common inherited cause of mental<br />
retardation. Patients with fragile X syndrome have cardiac defects<br />
similar to those seen in other disorders of connective tissue such as<br />
Marfan’s syndrome and Ehlers-Danlos syndrome. These, and other<br />
somatic features, suggest an underlying connective tissue dysplasia.<br />
The underlying connection between Fragile X Mental Retardation<br />
Protein (FMRP) and the connective tissue dysplasia seen in FXS is<br />
still unclear. The limited numbers of studies evaluating cardiovascular<br />
aspects of FXS have yielded different results. In this study, transthoracic<br />
echocardiogram and ECG were available in 34 male participants.<br />
Mean age was 9,17 years [2-34 yrs]. There were two adult patients,<br />
one with mitral valve prolapsus (MVP), the other with aortic insuffi-<br />
ciency. The mean age of participants under 18 years was 8,06 (the<br />
eldest 17 years old). We compared our results with the data provided<br />
in the largest study yet (n=40) by Loehr et al. (<strong>19</strong>86). The comparison<br />
suggests that the prevalence of MVP is somewhat lower 8/32 (25%)<br />
in our study, while it was 35.2% in the latter, with a similar mean age<br />
of 8.6 years, while aortic annulus dilation was higher in the current<br />
study, 5/32 (15,6%) versus (10%). There was no significant correlation<br />
between metacarpophalangeal joint hyperextensibility and MVP. This<br />
data supports previous recommendations towards routine echocardiographic<br />
evaluation in individuals with FXS. Re-evaluation of the same<br />
group especially follow-up measurements of aortic annulus diameters<br />
in our ongoing longitudinal study will reveal the natural history of cardiac<br />
complications in FXS.<br />
P0117. Audiological evaluation of 63 males with Fragile X<br />
D. Aktas, Y. Alanay, G. Utine, B. Volkan-Salancı, A. Genç, F. Başer, S. Sevinç,<br />
U. Akyol, K. Boduroğlu, M. Alikaşifoğlu, E. Belgin, E. Tunçbilek;<br />
Hacettepe University, Ankara, Turkey.<br />
Fragile X syndrome is the most common inherited cause of mental<br />
retardation. Medical problems other than cognitive and behavioural issues<br />
have been rarely addressed in individuals with FXS.<br />
In this study 36 individuals molecularly diagnosed with FXS were evaluated.<br />
Mean age of the participants was 8,41 yrs [1,5-27]. Median IQ<br />
score was 45 [25-103] Seventy-two percent were having occupational<br />
therapy, while 25% also attended a public school.<br />
ENT examination revealed cerumen in 12 (33%), opaque ear drum in 4<br />
(11%) Audiologic evaluation revealed normal hearing in 29 participants<br />
(80,5), while 7 (<strong>19</strong>,5) had minimal conductive type hearing loss. In general<br />
, infants from birth to 6 months underwent observation audiometry;<br />
children between 6-36 months of age underwent Visual Response Audiometry<br />
(VRA) in soundfield; and children 36 months of age and older<br />
underwent play audiometry in soundfield or with earphones according<br />
to the degree of the child’s cooperation. Cooperation problems due<br />
to mental retardation affected this rule negatively. <strong>19</strong> non-cooperative<br />
patients (52,78%)(age range 7-27 yrs) were tested by VRA or play<br />
audiometry. In 7 patients(<strong>19</strong>,45%), suprathresholds responses were<br />
observed. For these patients, objective test methods were used effectively<br />
for final decision. There was no correlation between IQ scores<br />
and hearing status. Objective test methods were more feasible for diagnose<br />
in patients with Fragil X syndrome. Mean age at diagnosis was<br />
significantly lower in the group with hearing loss. This may reflect the<br />
earlier referral to a physician with recurrent infection or speech delay<br />
may have prompted earlier diagnosis.<br />
P0118. Fragile X syndrome in Estonia<br />
H. Puusepp 1,2 , T. Kahre 3 , I. Lind 3 , E. Raukas 3,4 , V. Soo 3 , H. Sibul 1,4 , A. Kurg 1 , K.<br />
Õunap 2,3 ;<br />
1 Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia, 2 Department<br />
of Pediatrics, University of Tartu, Tartu, Estonia, 3 United Laboratories,<br />
Tartu University Hospital, Tartu, Estonia, 4 Estonian Biocentre, Tartu, Estonia.<br />
The Fragile X syndrome is the most common human chromosomal<br />
monogenic disease associated with heritable mental retardation, and<br />
is the second most frequent cause of mental retardation after Down<br />
syndrome. Our study consists of the screening of 561 Estonian children<br />
having mental retardation, autism, delayed speech and/or behavioral<br />
problems. The patient samples were sent to the United Laboratories<br />
of Tartu University Hospital for screening of fragile X mutation from<br />
year <strong>19</strong>97 to 2006. The molecular study for the diagnosis has been<br />
performed by two different techniques. During <strong>19</strong>97-2001 the Southern<br />
blot analysis and later PCR with fluorescently marked primers followed<br />
by CGG repeat length detection at ABI PRISM 377 was used.<br />
Among 561 (477 boys/84 girls) patients we found 15 full mutations<br />
(14 boys/ 1 girl), and 1 premutation in a girl. The main indication for<br />
the analysis in diagnosed boys was mental retardation in 11 patients,<br />
autism in 2 patients, and characteristic phenotype in 1 patient. The girl<br />
with a full mutation was investigated due to psychomotor retardation<br />
and delayed speech. The girl with a premutation had mild mental retardation<br />
and primary ovarian failure. The birth prevalence of full mutation<br />
in FMR1 gene causing fragile X syndrome is 1 in 25,308 among<br />
individuals born during <strong>19</strong>84-2006. We found that birth prevalence of<br />
the fragile X syndrome is significantly lower in Estonia than in other<br />
countries. The reason for that is still unknown for us.<br />
1